Table 1.
Type of cells | Immune players influenced at injury milieu | Effects on recovery | Citations |
---|---|---|---|
Neural stem cells (NSCs) | FGF2 HGF CD133+/CD34−/CD45− Neurogenin-2 GSI |
Facilitatory Facilitatory Facilitatory Facilitatory Tumor inhibition |
[55] [61] [62] [67] [72] |
| |||
Schwann cells (SCs) | p75 GFAP S100 L1 N-CAM NGF BDNF GDNF CNTF IL-10 Fibronectin Laminin |
Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory |
[3, 74] [3, 74] [3, 74] [3, 74] [3, 74] [78–81] [78–81] [78–81] [78–81] [86–88] [74] [74] |
| |||
Olfactory ensheathing cells (OECs) | p75 GFAP S100 L1 N-CAM Fibronectin Laminin |
Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory |
[3, 74] [3, 74] [3, 74] [3, 74] [3, 74] [74] [74] |
| |||
Ependymal cells | EGF FGF2 |
Facilitatory Facilitatory |
[107] [107] |
| |||
Human central nervous system stem cell (HuCNS-SC) | Further studies needed | Facilitatory | [109] |
| |||
Erythropoietin-releasing neural precursors cells (Er-NPCs) | Macrophages rhEPO 5-TH GAP43 BDNF NGF β-Tubulin III MAP-2 |
Inhibitory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory |
[31, 112] [117] [31, 116, 117] [31, 118–120] [116, 122, 123] [116, 122, 123] [31] [31] |
| |||
Mesenchymal stem cells (MSCs) | 5-HT GAP43 BDNF VEGF FGF2 MAP-2 GABA-A BNP TGF-β |
Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory |
[137] [128, 147] [4, 148] [4, 148] [4, 148] [4, 151] [4, 151] [4, 152, 153] [4, 161, 162] |
| |||
Induced pluripotent stem cells (iPSCs) | GSI HSVtk GCV |
Tumor inhibition Tumor inhibition Tumor inhibition |
[1] [1] [1] |
| |||
Umbilical cord blood cells (UCBCs) | CD34+/CD45− CD133+ |
Facilitatory Facilitatory |
[3] [3] |